India's Biocon to file for Syngene unit's IPO in 2 months -sources

MUMBAI, March 31 (Reuters) - Indian biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources directly involved in the process said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.